Abstract
High Performance Liquid Chromatography(HPLC) is a versatile tool in radiopharmaceutical chemistry. Instrumentation, methods and applications have been reviewed as recently as 19861. HPLC has been used for numerous areas associated with the production of radiopharmaceuticals including:
-
analysis of radiochemical and chemical starting materials;
-
determination of both labelled and unlabelled reaction products;
-
optimization of reaction conditions;
-
purification, including separation from chemical and radiochemical impurities;
-
determination of specific activity;
-
determination of radiochemical and chemical purity;
-
determination of the stability of the radiolabelled product during storage, including determination of radiolysis products;
-
validation of other methods of analysis, such as TLC;
-
determination of metabolites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. Wieland, M. Tobes, and T. Mangner, ed., “Analytical and Chromatographic Techniques in Radiopharmaceutical Chemistry”, Springer-Verlag, New York (1986).
The United States Pharmacopeia, XXII, The United States Pharmacopeial Convention, Inc., Rockville, MD (1989).
C. Dorschel, J. Ekamanis, J. Oberholtzer, F. Warren, Jr. and B. Bidlingmeyer, LC Detectors: Evaluation and Practical Implications of Linearity, Anal. Chem. 61: 951A (1989).
T. Boothe, R. Finn, M. Vora, A. Emran, P. Kothari and S. Wukovnig, Increasing Role of High Performance Liquid Chromatography (HPLC) in Radiopharmaceutical Analysis, in “Synthesis and Applications of Isotopically Labeled Compounds 1985”, R. Muccino, ed., Elsevier Science Publishers, Amsterdam (1986).
T.-Z. Zhou, W. Hirth, W. Heineman and E. Deutsch, Quantitative HPLC Determination of [99mTc]Pertechnetate in Radiopharmaceuticals and Biological Samples-I. Technique Development, Nucl. Med. Biol. 15: 493 (1988).
R. Nieuwland, H. Das and C. de Ligny, Improvement of the Reproducibility of Ion-Pair HPLC of 99mTc(Sn)EHDP Complexes and the Influence of the Sn(II) Concentration on the Composition of the Reaction Mixture, Appl. Radiat. Isop. 40: 153 (1989).
T. Tji, H. Vink, W. Gelsema and C. de Ligny, Determination of the Oxidation State of Tc in 99Tc(Sn)EHDP, 99mTc(Sn)EHDP, 99Tc(Sn)MDP and 99mTc(Sn)MDP Complexes. Characterization of Tc(III)-, Tc(IV)- and Tc(V)EHDP Complexes, Appl. Radiat. Isot. 41: 17 (1990).
Y. Huigen, W. Gelsema and C. de Ligny, Separation of 99mTc(Sn)-EHDP Complexes by Chromatography on TSK G 2000 PW, Using Its Ion Exchange Properties, Appl. Radiat. Isop. 41: 335 (1990).
M. Holland, W. Heineman and E. Deutsch, Technetium-99m Complexes of Dimethylaminomethylene Diphosphonate(DMAD)-I. Anion Exchange HPLC Characterization of 99mTc(NaBH4)-DMAD Mixtures, Nucl. Med. Biol. 16: 301 (1989).
M. Holland, J. Bugaj, W. Heineman and E. Deutsch, Technetium-99m Complexes of Dimethylaminomethylene Diphosphonate(DMAD)-II. Biological Distributions of 99mTc-DMAD Components Isolated by Anion Exchange HPLC, Nucl. Med. Biol. 16: 313 (1989).
H. Kung, B.-L. Liu and S. Pan, Kinetic Study of Ligand Exchange Reaction Between 99mTc-Glucoheptonate and N-Benzyl-N-methyl-piperazinyl-bis(aminoethanethiol)(BPA-BAT), Appl. Radiat. Isop. 40: 677 (1989).
J. Baldas, J. Bonnyman and Z. Ivanov, Use of High Performance Liquid Chromatography for the Structural Identification of Technetium-99m Radiopharmaceuticals at the NCA Level, J. Nucl. Med. 30: 1240 (1989).
M. Corlija, K. Tubergen, W. Volbert and R. Holmes, Contribution of Radiolytically Induced Dissociation of 99mTc-d,l-HMPAO in Aqueous Solutions, J. Nucl. Med. 31: 806 (abstract) (1990).
M. Marmion, K. Libson and E. Deutsch, New Mixed Tc/Sn Complexes: Relevance to Nuclear Medicine, J. Nucl. Med. 31: 807 (abstract) (1990).
A. Nunn, HPLC as the Archetypical Animal, Nucl. Med. Biol. 16: 187 (1989).
A. Zimmer, J. Kazikiewicz, S. Spies and S. Rosen, Rapid Miniaturized Chromatography for 111In Labeled Monoclonal Antibodies: Comparison to Size Exclusion High Performance Liquid Chromatography, Nucl. Med. Biol. 15: 717 (1988).
J. Reynolds, S. Del Vecchio, H. Sakahara, M. Lora, J. Carrasquilla, R. Neumann and S. Larsen, Anti-murine Anitibody Response to Mouse Monoclonal Antibodies: Clinical Findings and Implications, Nucl. Med. Biol. 16: 121 (1989).
P. Garg, G. Archer Jr., D Bigner and M. Zalutsky, Synthesis of Radioiodinated N-Succinimidyl Iodobenzoate: Optimization for Use in Antibody Labelling, Appl. Radiat. Isop. 40: 485 (1989).
M. Himmelbach and R. Wahl, Studies on the Metabolic Fate of 111In-labeled Antibodies, Nucl. Med. Biol. 16: 839 (1989).
K. Yokoyama, J. Reynolds, C. Paik, V. Sood, P. Maloney, S. Larson and R. Reba, Immunoreactivity Affects the Biodistribution and Tumor Targzting of Radiolabeled Anti-P97 Fab Fragment, J. Nucl. Med. 31: 202 (1990).
J. Zielinski, J. Larner, P. Hoffer and R. Hochberg, The Synthesis of llßMethoxy-[16a-123I]Iodoestradiol and Its Interaction with the Estrogen Receptor In Vivo and In Vitro, J. Nucl. Med. 30: 209 (1989).
J. Ulin, A. Gee, P. Malmborg, J. Tedroff and B. Langstrom, Synthesis of Racemic (+) and (-) N-[methyl-11C]nomifensine, a Ligand for Evaluation of Monoamine Re-Uptake Sites by Use of Positron Emission Tomography, Apol. Radiat. Isop. 40: 171 (1989).
J. Vlek, K. Feitsma, T. van der Mark, B. Drenth, A. Paans and W. Vaalburg, Synthesis of d-[11C]Oxyphenonium Iodide, a Potential Radioligand for In Vivo Visualization of Human Cholinergic Muscarinic Receptor-sites by Positron Emission Tomography, Appl. Radiat. Isop. 41: 453 (1990).
M. Maeda, Y. Koga, T. Fukumura and M. Kojima, d-[11C]Octopamine Synthesis Using [11C]Cyanide: Chemical and Enzymatic Approaches for the [11C]Cyanohydrin Synthesis, Appl. Radiat. Isop. 41: 463 (1990).
K. Suzuki, O. Inoue, K. Tamate and F. Mikado, Production of 3-N[11C]Methylspiperone with High Specific Activity and High Radiochemical Purity for PET Studies: Suppression of Its Radiolysis, Appl. Radiat. Isop. 41: 593 (1990).
S. Moerlein, D. Parkinson and M. Welch, Radiosynthesis of High Effective Specific-activity [123I]SCH 23982 for Dopamime D-1 Receptor-based SPECT Imaging, Appl. Radiat. Isop. 41: 381 (1990).
N. Satyamurthy, J. Barrio, G. Bida, S.-C. Huang, J. Mazziotta and M. Phelps, 3-(2’-[18F]Fluoroethyl)spiperone, a Potent Dopamime Antagonist: Synthesis, Structural Analysis and In-Vivo Utilization in Humans, Appl. Radiat. Isop. 41: 113 (1990).
D. Kiesewetter, R. Kawai, M. Chelliah, E. Owens, C. McLellan and R. Blasberg, Preparation and Biological Evaluation of 18F-labeled Benzamide Analogues as Potential Dopamine D2 Receptor Ligands, Nucl. Med. Biol. 17: 347 (1990).
D. Kiesewetter, K. Rice, M. Mattson and R. Finn, Radiochemical Synthesis of [18F]-Fluo rot hienylcyclohexylpiperdine([18F]FTCP), J. Labelled Compd. Radiopharm. 27: 277 (1989).
M. Adam, J. Grierson and S. Jivan, An Improved HPLC System for the Analysis and Purification of Organic Amine Radiopharmaceuticals, Appl. Radiat. Isot. 40: 91 (1989).
W. Rzeszotarski, W. Eckelman and B. Francis, Synthesis and Evaluation of Radioiodinated Derivatives of 1-Azabicyclo(2.2.2)oct-3-yl alphahydroxy-alpha-(4-iodophenyl)phenylacetate as Potential Radiopharmaceuticals, J. Med. Chem. 27: 156 (1984).
A. Emran, Radiofluorination of Aromatic Acids for Application in Receptor Studies, in “Proceedings of the 199th ACS National Meeting”, Boston, MA, April (1990).
C. Prenant, L. Barre and C. Crouzel, Synthesis of [11C1–3- Quinuclidinylbenzilate(QNB), J. Labelled Compd. Radiopharm. 27: 1257 (1989).
S. Ram and L. Spicer, Direct Incorporation of [11C]Carbon Dioxide for Labeling Bioactive Molecules. An Application to [11c] Labeled Tamoxifen, J. Labelled Compd. Radiopharm. 27: 661 (1989).
D. Yang, A. Emran, W. Tansey, R. Tilbury, L. Kasi, K. Wright, L. Kuang, S. Wallace, and E. Kim, Radiosynthesis of Fluorotamoxifen Analogs, J. Nucl. Med. 31: 903 (abstract) (1990).
M. Adam and S. Jivan, Synthesis and Purification of L-6-[18F]Fluorodopa, Appl. Radiat. Isop. 39: 1203 (1988).
J. Chen, S.-J Huang, R. Finn, K. Kirk, B. Francis, H. Adams, R. Cohen and C. Chiueh, Quality Control Procedure for 6-[18F]Fluoro-L-DOPA: A Presynaptic PET Imaging Ligand for Brain Dopamine Neurons, J. Nucl. Med. 30: 1249 (1989).
V. Pike, M. Kensett, D. Turton, S. Waters and D. Silvester, Labelling Agents for PET Studies of the Dopaminergic System-Some Quality Assurance Methods, Experiences and Issues, Appl. Radiat. Isop. 41: 483 (1990).
C. Lemaire, M. Guillaume, R. Cantineau and L. Christiaens, No-CarrierAdded Regioselective Preparation of 6-[18F]Fluoro-L-DOPA, J. Nucl. Med. 31: 1247 (1990).
H. Coenen, K. Franken, P. Kling and G. Stoecklin, Direct Electrophilic Radiofluorination of Phenylalanine, Tyrosine and DOPA, Appl. Radiat. Isop. 39: 1243 (1988).
O. DeJesus, J. Sunderland, J. Nickles, J. Mukherjee and E. Appelman, Synthesis of Radiofluorinated Analogues of m-Tyrosine as Potential L-Dopa Tracers via Direct Reaction with Acetylhypofluorite, Appl.Radiat. Isop. 41: 433 (1990).
A. Gelbard, A. Cooper, Y. Asano, E. Nieves, S. Filc-Dericco and K. Rosenspire, Methods for the Enzymatic Synthesis of Tyrosine and Phenylalanine Labeled with Nitrogen-13, Appl. Radiat. Isop. 41: 229 (1990).
O. DeJesus, J. Mukherjee and R. Khalifah, Synthesis of Radiobrominated m-Tyrosine, J. Labelled Compd. Radiopharm. 27: 189 (1989).
M. Adam, Y. Ponce, J. Berry and K. Hoy, Synthesis and Preliminary Evaluation of L-6-[123I]Iododopa as a Potential Spect Brain Imaging Agent, J. Labelled Compd. Radiopharm. 28: 155 (1990).
B. Bauer and R. Wagner, Improved Synthesis of [150]Butanol for Clinical Use, in “Proceedings of the Eight Int. Symp. Radiopharm. Chem.”, Princeton, NJ, June (1990).
G. Gundlach, E. Sattler and U. Wagenbach, Preparation of Carrier-Free 11C-Amino Acids by Insertion of Hot 110-atoms into Valine and 2-Aminobutyric Acid with Retention of Optical Asymmetry, Appl. Radiat. Isop. 40: 637 (1989).
H. Svard, S.-B. Jigerius and B. Langstrom, The Enzymatic Synthesis of L[3–11C]Serine, Appl. Radiat. Isop. 41: 587 (1990).
K. Hamacher and J. Hanus, Synthesis of 1-[11C]-D,L-Homocysteine thiolactone: a Potential Tracer for Myocardial Ischemia using PET, J. Labelled Compd. Radiopharm. 27: 1275 (1989).
G. Antoni and B. Langstrom, Synthesis of -Amino[4–11C]ButyricAcid(GABA), J. Labelled Compd. Radiopharm. 27: 571 (1989).
A. Emran, Synthesis, Reactions and Applications of [11C]thiocyanate, J. Nucl. Med. 29: 1325 (1988).
S. Stone-Elander, P. Roland, C. Halldin, M. Hassan and R. Seitz, Synthesis of [11C]Sodium Thiocyanate for In Vivo Studies of Anion Kinetics Using Positron Emission Tomography(PET), Nucl. Med. Biol. 16: 741 (1989).
T. Boothe, A. Emran, R. Finn, m. Vora, and P. Kothari Use of 11C as a Tracer for Studying the Synthesis of [11C]Urea from [11C]Cyanide, Int. J. Appl. Radiat. Isop. 36: 141 (1985).
A. Emran, T. Boothe, R. Finn, M. Vora, and P. Kothari, Use of Liquid Chromatography for the Separation and Determination of Carrier Species Associated with the Synthesis of No-Carrier-Added [11C] Labelled Compounds: Determination of the Specific Activity of [11C]Urea, J. Radioanal. Nucl. Chem. 91: 277 (1985).
A. Emran, Synthesis of [13N] and/or [11C] Singly or Doubly Labelled Urea, in “Proceedings of the 197th ACS National Meeting”, Dallas, TX, September (1989).
A. Emran, T. Boothe, R. Finn, M. Vora, and P. Kothari, Use of 11C as a Tracer for Studying the Synthesis of Radiolabelled Coumpounds-II: 2[11C]-5,5-Diphenylhydantoin from [11C]Cyanide, Int. J. Appl. Radiat. Isop. 37: 1033 (1986).
A. Emran, T. Boothe, R. Finn, M. Vora, and P. Kothari, High Specific Activity Measurements Utilizing HPLC in “Proceedings of the 187th ACS National Meeting”, Washington, D.C., August (1983).
A. Emran, T. Boothe, N. Shanbaky, R. Finn, M. Vora, and P. Kothari, Rapid Simultaneous Determination of Diphenylhydantoin, its Major Metabolites and Degradation Products, in “Proceedings of the 192th ACS National Meeting”, Anaheim, CA, September (1986).
D. R. Hwang, L. Lang, C. Mathias, D. Kadmon and M. Welch, N-3[18F]Fluoropropylputrescine as Potential PET Imaging Agent for Prostate and Prostate Derived Tumors, J. Nucl. Med. 30: 1205 (1989).
F. Oberdorfer, E. Hofmann and W. Maier-Borst, Preparation of 18F-Labeled 5-Fluorouracil of Very High Purity, J. Labelled Compd. Radiopharm. 27: 137 (1989).
M. Vora and R. Lambrecht, Optimized Synthesis of Radioiodinated Rhodamine-123, J. Labelled Compd. Radiopharm. 27: 789 (1989).
M. Vora, Chromatography of Rhodamine 123 and Rhodamine 110 on Reverse-Phase Liquid Chromatographic Column, J.Liq.Chromatogr. 12: 583 (1989).
E. Knust, K. Dutschka and H.-J.Machulla, Radiopharmaceutical Preparation of 3–123I-a-methyltyrosine for Nuclear Medical Applications, J. Radioanal. Nucl. Chem. 144: 107 (1990).
Y. Ding, G. Antoni, J. Fowler, A. Wolf and B. Langstrom, Synthesis of L[5-TT C]Ornithine, J. Labelled Compd. Radiopharm. 27: 1079 (1989).
H. Coenen, V. Pike, G. Stoecklin and R. Wagner, Recommendation for A Practical Production of [2–18F]Fluoro-2-Deoxy-D-Glucose, Appl.Radiat. Isop. 38: 605 (1987).
T. Tewson, Procedures, Pitfalls and Solutions in the Production of [18F]2Deoxy-2-fluoro-D-Glucose: a Paradigm in the Routine Synthesis of Fluorine-18 Radiopharmaceuticals, Nucl. Med. Biol. 16: 533 (1989).
K. Hamacher, H. Coenen and G. Stoecklin, Efficient Stereospecific Synthesis of No-Carrier-Added 2-[18F]Fluoro-2-Deoxy-D-Glucose Using Aminopolyether Supported Nucleophilic Substitution, J. Nucl. Med. 27: 235 (1986).
M. Vora, T. Boothe, R. Finn, P. Kothari, A. Emran, S. Carroll and A. Gilson, Multimillicurie Preparation of 2-[18F1-Fluoro-2-Deoxy-DGlucose via Nucleophilic Displacement with Fluorine-18 Labelled Fluoride, J. Labelled. Compd. Radiopharm. 22: 953 (1985).
E. Kurst, R. Wortmann and H. Machulla, Synthesis of 2-Deoxy-2-[18F]fluoroD-glucose and 3-Deoxy-3-[18F]fluoro-D-glucose with No-Carrier-Added [18F]fluoride, J. Radioanal. Nucl. Chem. 132: 85 (1989).
S. Yamazaki, R. Iwata and T. Ido, Computer Controlled Synthesis of 2- Deoxy-2-[18F]Fluoro-D-Glucose from [18]Fluoride with Feedback Control, in “CYRIC Annual Report 1989”, 158 (1989).
S. Gatley, S. Brown and C. Thompson, Rapid, Inexpensive Quality Control of Fluorine-18 2-Deoxy-2-Fluoro-D-Glucose Preparations Using the Hexokinase Reaction In Vitro, J. Nucl. Med. 29: 1443 (1988).
F. Oberdorfer, W. Hull, B. Travingq and W. Maier-Borst, Synthesis and Purification of 2-Deoxy-2-[1 F]fluoro-D-glucose and 2-Deoxy-2- [18F]fluoro-D-mannose: Characterization of Products by 1H- and 18F-NMR Spectroscopy, Appl. Radiat. Isop. 37: 695 (1986).
F. Oberdorfer, K. Kemper and K. Gottschall, Application of Ion Chromatography to the Analysis of 18F-Labelled Deoxyaldohexoses. An Improved System for Monitoring the Chemical Purity of 2-Deoxy-2-[1 F]fluoro-D-glucose and 2-Deoxy-2-[18F]fluoro-D- galactose, in “Proceedings of the Eight mt. Symp. Radiopharm. Chem.”, Princeton, NJ, June (1990).
D. Alexoff, R. Casati, J. Fowler, A. Wolf, C. Shea, D. Schlyer and C.-Y. Shiue, Ion Chromatographic Analysis of 18FDG Produced by [18F]fluoride Displacement: Production of 2-Chloro-2-Deoxy-D-Glucose as an Impurity in the Presence of Chloride Ion, in “Proceedings of the Eight Int. Symp. Radiopharm. Chem.”, Princeton, NJ, June (1990).
Solin, J. Bergman, M. Haaparanta and A. Reissell, Production of 18F from Water Targets. Specific Radioactivity and Anionic Contaminants, Appl. Radiat. Isop. 39: 1065 (1988).
M. Suehiro, M. Iwamoto, I. Arai and T. Nozaki, Bromination, No-CarrierAdded Radiobromination and Simultaneously-occurring Chlorination by Chloramine T, Appl. Radiat. Isop. 41: 439 (1990).
A. Zimmer, J. Kazikiewicz, S. Rosen and S. Spies, Chromatographic Evaluation of the Radiochemical Purity of Na131I: Effect or Monoclonal Antibody Labeling, Nucl. Med. Biol. 14: 533 (1987).
M. Sajjad, R. Lambrecht and S. Bakr, Chromatographic Evaluation of the Radiochemical Purity of Reductant-Free Iodine-123, Nucl. Med. Biol. 15: 721 (1988).
L. Mausner, S. Srivastava, S. Mirzadeh, G. Meinken and T. Prach, 123I Research and Production at Brookhaven National Laboratory, Appl. Radiat. Isop. 37: 843 (1986).
T. Boothe, A. Emran, R. Finn, P. Kothari and M. Vora, Chromatography of Radiolabelled Anions Using Reversed-Phase Liquid Chromatographic Columns, J. Chromatoor. 333: 269 (1985).
T. Boothe, R. Finn, M. Vora, A. Emran, P. Kothari and G. Kabalka, Radioiodinations of Organic Molecules on Silica Gel Surfaces, J. Labelled Compd. Radiopharm. 22: 1109 (1985).
T. Boothe, P. Kothari, P. Smith, E. Tavano and D. Kinney, Evaluation of Several HPLC Column Systems for Anion and Cation Determination in Radiochemical/Radiopharmaceutical Analysis, in “Proceedings of the 198th ACS National Meeting”, Miami Beach, September (1989).
A. Emran, L. Bolomey, R. Tilbury and M. Drew, Continuous Flow System for the Production of 13N-Labelled Tracers to Study Nitrogen Transport and Metabolism, in “Proceedings of the 198th ACS National Meeting”, Miami Beach, FL, September (1989).
J. Brodack, M. Kilbourn and M. Welch, Automated Production of Several Positron-Emitting Radiopharmaceuticals Using a Single Laboratory Robot, A001. Radiat. Isop. 39: 689 (1988).
A. Luven, M. Perlmutter, G. Bida, G. VanMoffaert, J. Cook, N. Satyamurthy, M. Phelps and J. Barrio, Remote, Semiautomated Production of 6[18F]Fluoro-L-Dopa for Human Studies with PET, Appl. Radiat. Isop. 41: 275 (1990).
T. Ruth, M. Adam, S. Jivan, D. Morris and S. Tyldesley, An Automated Synthesis of L-6-[18F]Fluorodopa, in “Proceedings of the Eight Int. Symp. Radiopharm. Chem.”, Princeton, NJ, June (1990).
A. Plenevaux, R. Cantineau, D. Labar, C. Lemaire and M. Guillaume, Routine Production and Improvement in the Purification of 3-N-(2’[18F]Fluoroethyl)spiperone for Clinical Use, in “Proceedings of the Eight Int. Symp. Radiopharm. Chem.”, Princeton, NJ, June (1990)
K. Hamacher, B. Nebeling, H. Coenen and G. Stoecklin, [18F]NMethylspiperone: Direct N.C.A. Nucleophilic [18F]Fluorination of NMethyl-4-nitrospiperone for Remote Controlled Routine Production of N.C.A. [18F]MSP, in “Proceedings of the Eight Int. Symp. Radiopharm. Chem.”, Princeton, NJ, June (1990).
M. Channing, P. Plascjak, W. Meyer, Jr., N. Simpson, Y. Sheh, R. Adams, D. Kiesewetter, B. Dunn and R. Finn, Radiochemical Automation Achieved through a Modified Autosampling Devise, Nucl. Inst. Meth. Phvs. Res. B40 /41: 1121 (1989).
M. Senda, M. Suchiro, T. Sasaki, H. Toyama, K. Kitani, K. Miki, T. Hiroishi, H. Suzuki, T. Hiasa and Y. Miyake, Automated Quality Test of Positron Emitting Radiopharmaceuticals in a Clinical PET Center, Eur. J. Nucl. Med. 16 (Suppl): S73 (1990).
K. Rosenspire, W. Hirth, S. Jurisson, D. Nowotnik, W. Eckelman and A. Nunn, Direct Chromatographic Analysis of Metabolites of Lipophilic Tracers in Whole Blood by ISRP Chromatography, in “Proceedings of the Eight Int. Symp. Radiopharm. Chem.”, Princeton, NJ, June (1990).
O. Solin, M. Haaparanta, J. Sunderland, O. de Jesus and R. Nickles, A ß- Flow-Through Detector for HPLC Analysis of PET Metabolites, J. Nucl. Med. 31: 749 (abstract) (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Boothe, T.E., Emran, A.M. (1991). The Role of High Performance Liquid Chromatography in Radiochemical/Radiopharmaceutical Synthesis and Quality Assurance. In: Emran, A.M. (eds) New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0626-7_38
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0626-7_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0628-1
Online ISBN: 978-1-4899-0626-7
eBook Packages: Springer Book Archive